PRP in ACLR to Prevent PTOA — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PRP in ACLR to Prevent PTOA — Stella

Recruiting

Back to Anterior Cruciate Ligament Injuries trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

Hospital for Special Surgery, New York, New York

Key details

Phase

Large-scale testing

Sponsor

Hospital for Special Surgery, New York

Collaborators

Orthopedic Research and Education Foundation

Enrollment target

~56 participants

Started

June 2022

Primary completion

December 2026

Age range

14 Years – 50 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov